A Novel Approach to Targeting DLL3 with Tarlatamab in a Patient with Medullary Thyroid Carcinoma after Progression on Selpercatinib. - Roberts TJ; Meador CB; Fuld AD; Lasko A; Frigault M; Hangar KM; Reynolds K; Sadow PM; Wirth LJ (Thyroid : official journal of the American Thyroid Association, 2026)